⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Official Title: INTELLANCE-2: ABT-414 Alone or ABT-414 Plus Temozolomide Versus Lomustine or Temozolomide for Recurrent Glioblastoma: A Randomized Phase 2 Study of the EORTC Brain Tumor Group

Study ID: NCT02343406

Conditions

Glioblastoma

Study Description

Brief Summary: This study was conducted to evaluate the efficacy and safety of depatuxizumab mafodotin (ABT-414) alone or with temozolomide versus temozolomide or lomustine alone in adult participants with recurrent glioblastoma. The study also included a substudy to evaluate safety, tolerability and pharmacokinetics of ABT-414 in a pediatric population.

Detailed Description: The study objectives were to assess whether depatuxizumab mafodotin (ABT-414) alone or in combination with temozolomide (TMZ) improved overall survival (OS), progression-free survival (PFS), tumor response, quality of life, neurological deterioration-free survival (NDFS), and steroid use compared to standard treatment with lomustine single agent or TMZ re-challenge in adult subjects ≥ 18 years of age with centrally-confirmed recurrent epidermal growth factor receptor (EGFR)-amplified glioblastoma. The safety, pharmacokinetics, and efficacy of depatuxizumab mafodotin in children \<18 years of age was evaluated in a pediatric substudy. The EMEA-001732-PIP02-15 pediatric investigation plan was withdrawn on 07 July 2019 due to the discontinuation of the depatuxizumab mafodotin research program.

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Lucile Packard Children's Hosp /ID# 153678, Palo Alto, California, United States

Children's Hospital Colorado /ID# 153677, Aurora, Colorado, United States

Univ of Colorado Cancer Center /ID# 134882, Aurora, Colorado, United States

Sarah Cannon Research Institute at HealthONE - Denver /ID# 141798, Denver, Colorado, United States

Rush University Medical Center /ID# 137542, Chicago, Illinois, United States

Dana-Farber Cancer Institute /ID# 154210, Boston, Massachusetts, United States

Long Island Brain Tumor Center /ID# 134496, Lake Success, New York, United States

Weill Cornell Medicine /ID# 152656, New York, New York, United States

Cleveland Clinic Main Campus /ID# 137540, Cleveland, Ohio, United States

University of Pittsburgh MC /ID# 134491, Pittsburgh, Pennsylvania, United States

Tennessee Oncology, PLLC /ID# 134492, Nashville, Tennessee, United States

UT Southwestern Medical Center /ID# 136718, Dallas, Texas, United States

Swedish Medical Center /ID# 136719, Seattle, Washington, United States

Port Macquarie Base Hospital /ID# 134569, Port Macquarie, New South Wales, Australia

Sydney Children's Hospital /ID# 153533, Randwick, New South Wales, Australia

Royal North Shore Hospital /ID# 147092, Saint Leonards, New South Wales, Australia

Calvary Mater Newcastle /ID# 134570, Waratah, New South Wales, Australia

Southern Medical Day Care Ctr /ID# 134495, Wollongong, New South Wales, Australia

Royal Brisbane and Women's Hospital /ID# 147091, Herston, Queensland, Australia

Royal Adelaide Hospital /ID# 135208, Adelaide, South Australia, Australia

Royal Hobart Hospital /ID# 135209, Hobart, Tasmania, Australia

Barwon Health University Hospital Geelong /ID# 134493, Geelong, Victoria, Australia

Royal Children's Hospital /ID# 157624, Melbourne, Victoria, Australia

University Hospital St. Polten /ID# 139070, St. Pölten, Niederoesterreich, Austria

LKH-Univ. Klinikum Graz /ID# 139071, Graz, , Austria

Kepler Universitätsklinikum GmbH - Neuromed Campus /ID# 139068, Linz, , Austria

Cliniques Universitaires Saint Luc /ID# 139391, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium

Grand Hôpital de Charleroi /ID# 139342, Charleroi, Hainaut, Belgium

UZ Gent /ID# 152944, Gent, Oost-Vlaanderen, Belgium

AZ St-Jan Brugge-Oostende AV /ID# 137927, Brugge, West-Vlaanderen, Belgium

ZNA Middelheim /ID# 137926, Antwerp, , Belgium

UZ Leuven /ID# 137925, Leuven, , Belgium

Montreal Neurological Institut /ID# 136309, Montreal, Quebec, Canada

Fakultni Nemocnice v Motole /ID# 139509, Prague 5, Praha 5, Czechia

Masarykuv onkologikcy ustav /ID# 139508, Brno, , Czechia

FN Hradec Kralove /ID# 139510, Hradec Kralove, , Czechia

Univ Hosp Ostrava-Poruba /ID# 139507, Ostrava, , Czechia

Helsinki Univ Central Hospital /ID# 140078, Helsinki, , Finland

Helsinki Univ Central Hospital /ID# 153069, Helsinki, , Finland

Turku University Hospital /ID# 140861, Turku, , Finland

CHRU Lille - Hôpital Claude Huriez /ID# 137916, Lille CEDEX, Hauts-de-France, France

Centre Oscar Lambret /ID# 169619, Lille, Hauts-de-France, France

CHU-Hopital Avicenne /ID# 137910, Bobigny, Ile-de-France, France

Gustave Roussy /ID# 137912, Villejuif, Ile-de-France, France

Institut de Cancer de l'Ouest /ID# 137914, St Herblain CEDEX, Loire-Atlantique, France

Hopital de la Timone /ID# 137911, Marseille CEDEX 05, Provence-Alpes-Cote-d Azur, France

CHU de Nice /ID# 137917, Nice CEDEX 1, Provence-Alpes-Cote-d Azur, France

Centre Leon Berard /ID# 137918, Lyon CEDEX 08, Rhone, France

Institut de Cancer de l'Ouest /ID# 137909, Angers, , France

Hospices Civils de Lyon /ID# 137913, Bron, , France

Hopital Pitie Salpetriere /ID# 145887, Paris, , France

Universitaetsklinik Heidelberg /ID# 137924, Heidelberg, Baden-Wuerttemberg, Germany

Universitatsklinik Regensburg /ID# 137920, Ratisbon, Bayern, Germany

Univ Klinik Eppendorf Hamburg /ID# 137921, Hamburg, , Germany

LMU Klinikum der Universität München /ID# 137922, Munich, , Germany

Universitatsklinikum Tubingen /ID# 137923, Tuebingen, , Germany

Pecsi Tudomanyegyetem /ID# 136111, Pécs, Pecs, Hungary

Semmelweis Egyetem /ID# 152578, Budapest, , Hungary

National Institute of Oncology /ID# 135970, Budapest, , Hungary

Orszagos Klinikai Idegtudomany /ID# 135971, Budapest, , Hungary

Debreceni Egyetem Klinikai Központ /ID# 135969, Debrecen, , Hungary

Cork University Hospital /ID# 136828, Cork, , Ireland

Beaumont Hospital /ID# 136829, Dublin, , Ireland

Ospedale Bellaria.Azienda USL IRCCS.Istituto delle Scienze Neurologiche di Bolog /ID# 138335, Bologna, , Italy

Ospedale Generale di Bolzano /ID# 138338, Bolzano, , Italy

Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 140395, Milan, , Italy

Istituto Oncologico Veneto /ID# 138336, Padova, , Italy

Azienda Ospedaliera Sant' Andrea /ID# 138337, Rome, , Italy

Seoul National Univ Bundang ho /ID# 136841, Seongnam, Gyeonggido, Korea, Republic of

Samsung Medical Center /ID# 136842, Seoul, Seoul Teugbyeolsi, Korea, Republic of

Seoul National University Hospital /ID# 136840, Seoul, , Korea, Republic of

Hospital Zambrano Hellion /ID# 138076, San Pedro Garza García, , Mexico

Vrije Universiteit Medisch Centrum /ID# 137221, Amsterdam, , Netherlands

Universitair Medisch Centrum Groningen /ID# 138266, Groningen, , Netherlands

Erasmus Medisch Centrum /ID# 136981, Rotterdam, , Netherlands

Haaglanden Medisch Centrum /ID# 137222, The Hague, , Netherlands

Universitair Medisch Centrum Utrecht /ID# 137219, Utrecht, , Netherlands

Prinses Maxima Centrum /ID# 204409, Utrecht, , Netherlands

Uniwersyteckie Centrum Kliniczne /ID# 137919, Gdansk, Mazowieckie, Poland

Wojewodzkie Wielospecjalistycz /ID# 137654, Lodz, , Poland

National University Hospital /ID# 135951, Singapore, , Singapore

National Cancer Ctr Singapore /ID# 135952, Singapore, , Singapore

KK Women's & Children Hospital /ID# 153676, Singapore, , Singapore

Instituto Catalán de Oncología (ICO) Badalona /ID# 140976, Badalona, Barcelona, Spain

Clinica Universitar de Navarra - Pamplona /ID# 140047, Pamplona, Navarra, Comunidad, Spain

Instituto Catalan de Oncologia (ICO) & Hosp. de Bellvitge /ID# 137688, Barcelona, , Spain

Hospital Universitario Nino /ID# 153800, Madrid, , Spain

Hosp Univ 12 de Octubre /ID# 137908, Madrid, , Spain

Centre Hospitalier Univ Vaudoi /ID# 137929, Lausanne, , Switzerland

University Hospital Zurich /ID# 137930, Zurich, , Switzerland

China Medical University Hosp /ID# 136976, Taichung City, Taichung, Taiwan

National Taiwan Univ Hosp /ID# 136975, Taipei City, Taipei, Taiwan

Taichung Veterans General Hosp /ID# 136977, Taichung City, , Taiwan

Taipei Veterans General Hosp /ID# 136974, Taipei City, , Taiwan

Linkou Chang Gung Memorial Ho /ID# 136944, Taoyuan City, , Taiwan

Guy's and St Thomas' NHS Found /ID# 140312, London, London, City Of, United Kingdom

Univ Hospitals Birmingham NHS Foundation trust /ID# 136978, Birmingham, , United Kingdom

Gartnavel General Hospital /ID# 136979, Glasgow, , United Kingdom

Hull and East Yorkshire NHS /ID# 136917, Hull, , United Kingdom

University College Hospitals /ID# 136879, London, , United Kingdom

Great Ormond St Hospital NHS /ID# 153421, London, , United Kingdom

Christie NHS Foundation Trust /ID# 140313, Manchester, , United Kingdom

Contact Details

Name: AbbVie Inc.

Affiliation: AbbVie

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: